322 related items for PubMed ID: 12848770
1. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP, Stenback S, Lipworth BJ.
Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
[Abstract] [Full Text] [Related]
2. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
4. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[Abstract] [Full Text] [Related]
5. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
Currie GP, Bates CE, Lee DK, Jackson CM, Lipworth BJ.
Eur J Clin Pharmacol; 2003 May; 59(1):11-5. PubMed ID: 12743669
[Abstract] [Full Text] [Related]
6. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[Abstract] [Full Text] [Related]
7. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008 Mar; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
8. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
9. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC, Lindemann L, Braun R, Steinkamp G.
Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
[Abstract] [Full Text] [Related]
10. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W, Goryachkina L, Jacques L, Frith L.
Clin Drug Investig; 2008 Jan 24; 28(2):101-11. PubMed ID: 18211118
[Abstract] [Full Text] [Related]
11. Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke.
Clearie KL, McKinlay L, Williamson PA, Lipworth BJ.
Chest; 2012 Feb 24; 141(2):330-338. PubMed ID: 21636667
[Abstract] [Full Text] [Related]
12. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
Chest; 1999 Sep 24; 116(3):595-602. PubMed ID: 10492259
[Abstract] [Full Text] [Related]
13. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
Chest; 1999 Sep 24; 116(3):625-32. PubMed ID: 10492263
[Abstract] [Full Text] [Related]
14. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
Allergy; 2003 Jul 24; 58(7):602-7. PubMed ID: 12823118
[Abstract] [Full Text] [Related]
15. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH.
Respir Med; 2003 May 24; 97(5):555-62. PubMed ID: 12735675
[Abstract] [Full Text] [Related]
16. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
Thorax; 1999 Mar 24; 54(3):207-12. PubMed ID: 10325895
[Abstract] [Full Text] [Related]
17. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb 24; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
18. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep 24; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
19. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
Respir Med; 2006 Jan 24; 100(1):2-10. PubMed ID: 16243498
[Abstract] [Full Text] [Related]
20. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED, International Study Group.
Respir Med; 2003 Mar 24; 97(3):234-41. PubMed ID: 12645830
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
